Calcium Channel Blockers: The Present and the Future

作者: John A. Pieper

DOI: 10.1002/J.1875-9114.1997.TB03732.X

关键词:

摘要: Over the past two decades, calcium channel blockers have been used extensively in treatment of hypertension, ischemic heart disease, and supraventricular arrhythmias. Since 1993, they most frequently class antihypertensive drugs; fact, 1995 accounted for 29% all drugs prescribed this patient population.', ' The reasons their extensive use are high degree efficacy; relatively low frequency serious adverse effects; lack effect on serum lipids: insulin resistance, renal hem~dynamics.~ In addition, reduce left ventricular mass hypertensive patients.* purpose editorial is to provide a perspective recent publications evaluating hypertension. I also discuss prospective, randomized trials that currently enrolling patients determine i f cardiovascular morbidity mortality patients. effectiveness reducing blood pressure compared with placebo other has demonstrated clearly widely publicized hypertension years, Treatment Mild Hypertension Study6 Veterans Affairs Cooperative Study Group Antihypertensive Agents.7, Despite impressive performance surrogate end point pressure, not shown nonfatal fatal complications or all-cause trial. fifth Joint National Committee Detection, Evaluation High Blood Pressure

参考文章(23)
Björn Dahlöf, Kjell Pennert, Lennart Hansson, Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. American Journal of Hypertension. ,vol. 5, pp. 95- 110 ,(1992) , 10.1093/AJH/5.2.95
Barry J Materson, Domenic J Reda, William C Cushman, Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents, Department of veterans affairs single-drug therapy of hypertension study Revised figures and new data American Journal of Hypertension. ,vol. 8, pp. 189- 192 ,(1995) , 10.1016/0895-7061(94)00196-I
Teri A Manolio, Jeffrey A Cutler, Curt D Furberg, Bruce M Psaty, Paul K Whelton, William B Applegate, Trends in Pharmacologic Management of Hypertension in the United States Archives of Internal Medicine. ,vol. 155, pp. 829- 837 ,(1995) , 10.1001/ARCHINTE.1995.00430080067009
Edward D. Frohlich, Alberto Zanchetti, Antihypertensive therapy: safety and efficacy of drugs and publications. Hypertension. ,vol. 27, pp. 317- 318 ,(1996) , 10.1161/01.HYP.27.3.317
N. M. Kaplan, Choice of initial therapy for hypertension JAMA: The Journal of the American Medical Association. ,vol. 275, pp. 1577- 1580 ,(1996) , 10.1001/JAMA.275.20.1577
M Epstein, Calcium antagonists: Still appropriate as first line antihypertensive agents American Journal of Hypertension. ,vol. 9, pp. 110- 121 ,(1996) , 10.1016/0895-7061(96)00013-1
Bertram L Kasiske, Jennie Z Ma, Roberto SN Kalil, Thomas A Louis, Effects of Antihypertensive Therapy on Serum Lipids Annals of Internal Medicine. ,vol. 122, pp. 133- 141 ,(1995) , 10.7326/0003-4819-122-2-199501150-00010
Julie E Buring, Robert J Glynn, Charles H Hennekens, Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA. ,vol. 274, pp. 654- 655 ,(1995) , 10.1001/JAMA.1995.03530080070044